Skip to content
healthcare.dev

MYCOPHENOLIC ACID

NDC 59651-621, MYCOPHENOLIC ACID, tablet, delayed release, from Aurobindo Pharma Limited.

Product NDC
59651-621
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218603
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-621 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MYCOPHENOLATE SODIUM180 mg/1

Pharmacologic classes

Antimetabolite Immunosuppressant [EPC]

Package NDCNDC-11Package
59651-621-0859651062108120 TABLET, DELAYED RELEASE in 1 BOTTLE (59651-621-08)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5b224d7f-fecb-4531-9d27-008347777c9d
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=59651-621
  • NADAC price for package 59651062108

    GET /v1/drugs/nadac/59651062108

Use it

Look up 59651-621 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-621 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-621. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.